Close

Dr Kwabena Asare

Research Fellow

London School of Hygiene & Tropical Medicine
Keppel street
London
United Kingdom

Kwabena joined the Electronic Health Records group in the Department of Non-Communicable Epidemiology in April 2024 as a Research Fellow. His research interests include using routinely collected observational data with robust causal inferential approaches to estimate causal effects of interventions and exposures for public health decision making. He is currently working with Professor Charlotte Warren-Gash on a number of projects related to infections, brain health and frailty during old age, using UK electronic health data from the Clinical Practice Research Database (CPRD) and US Veterans Health Administration (VHA). He holds a PhD in Public Health from University of KwaZulu-Natal, Durban, South Africa. His PhD research focused on contributing evidence to inform targeted interventions and healthcare policy to improve STI care in limited resource and HIV endemic settings in Sub-Saharan Africa. The evidence generated from his PhD involved identfying important risk factors for STI transmission and determing the impact of point-of-care testing for promt STI care versus centralised laboratory-based testing in South Africa. 

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Research

Research Area
Epidemiology
Electronic health records
Disease and Health Conditions
Non-communicable diseases
Mental health
HIV/AIDS
Sexually transmitted infections
Chronic diseases
Infectious diseases
Country
United Kingdom

Selected Publications

Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis
ASARE, K; Lewis, L; Van der Molen, J; Sookrajh, Y; Khubone, T; Ngwenya, T; Ntokozo, MS; Lessells, R; Naidoo, K; Sosibo, P; BOTTOMLEY, C; Garrett, N; Dorward, J;
2024
medRxiv
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study.
ASARE, K; Sookrajh, Y; Van der Molen, J; Khubone, T; Lewis, L; Lessells, RJ; Naidoo, K; Sosibo, P; Van Heerden, R; Garrett, N; Dorward, J;
2023
The Lancet Global health
Relationship between physical activity and behaviour challenges of adolescents in South Africa.
ASARE, K; Ntlantsana, V; Ranjit, K; Tomita, A; Paruk, S;
2023
The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa
Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa.
ASARE, K; Lewis, L; Van der Molen, J; Sookrajh, Y; Khubone, T; Moodley, P; Lessells, RJ; Naidoo, K; Sosibo, P; Garrett, N; Dorward, J;
2023
Open forum infectious diseases
Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa.
ASARE, K; Ngcapu, S; Osman, F; Mindel, A; Naicker, N; Khanyile, M; Karim, SS A; Tomita, A; Garrett, N;
2023
International journal of STD & AIDS
Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study
ASARE, K;
2023
Accreditation number: MDB015/MPDP/009/2023/09/HIVDR
Clinical outcomes after viraemia among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy in South Africa
ASARE, K; Lewis, L; Van der Molen, J; Sookrajh, Y; Khubone, T; Moodley, P; Lessells, R; Naidoo, K; Sosibo, P; Garrett, N; Dorward, J;
2023
medRxiv
Incidence of Herpes Simplex Virus type 2 infection among women living with Human Immunodeficiency Virus in South Africa
ASARE, K;
2023
Abstract ID: 1436705
See more information